【レポートの概要（一部）】
Table of Contents
Table of Contents 2
List of Tables 7
List of Figures 8
Introduction 9
Global Markets Direct Report Coverage 9
Chemotherapy Induced Neutropenia Overview 10
Therapeutics Development 11
Pipeline Products for Chemotherapy Induced Neutropenia – Overview 11
Pipeline Products for Chemotherapy Induced Neutropenia – Comparative Analysis 12
Chemotherapy Induced Neutropenia – Therapeutics under Development by Companies 13
Chemotherapy Induced Neutropenia – Therapeutics under Investigation by Universities/Institutes 16
Chemotherapy Induced Neutropenia – Pipeline Products Glance 17
Late Stage Products 17
Clinical Stage Products 18
Early Stage Products 19
Unknown Stage Products 20
Chemotherapy Induced Neutropenia – Products under Development by Companies 21
Chemotherapy Induced Neutropenia – Products under Investigation by Universities/Institutes 24
Chemotherapy Induced Neutropenia – Companies Involved in Therapeutics Development 25
Bio-Ker s.r.l 25
Biogenomics Limited 26
Bolder Biotechnology, Inc. 27
Cellerant Therapeutics, Inc. 28
Coherus BioSciences, Inc. 29
Dong-A Socio Group 30
Generon (Shanghai) Corporation Ltd. 31
Hanmi Pharmaceuticals, Co. Ltd. 32
Io Therapeutics, Inc. 33
Mycenax Biotech Inc. 34
Myelo Therapeutics GmbH 35
Octapharma AG 36
PharmaEssentia Corporation 37
Reliance Life Sciences Pvt. Ltd. 38
Richter Gedeon Nyrt. 39
Sandoz Inc. 40
Sandoz International GmbH 41
Teva Pharmaceutical Industries Limited 42
UAB Profarma 43
USV Limited 44
Welichem Biotech Inc. 45
XBiotech USA, Inc. 46
Chemotherapy Induced Neutropenia – Therapeutics Assessment 47
Assessment by Monotherapy Products 47
Assessment by Target 48
Assessment by Mechanism of Action 50
Assessment by Route of Administration 52
Assessment by Molecule Type 54
Drug Profiles 56
balugrastim – Drug Profile 56
Product Description 56
Mechanism of Action 56
R&D Progress 56
BBT-007 – Drug Profile 58
Product Description 58
Mechanism of Action 58
R&D Progress 58
BBT-015 – Drug Profile 59
Product Description 59
Mechanism of Action 59
R&D Progress 59
BBT-018 – Drug Profile 60
Product Description 60
Mechanism of Action 60
R&D Progress 60
BK-0026 – Drug Profile 61
Product Description 61
Mechanism of Action 61
R&D Progress 61
Cell Therapy for Chemotherapy Induced Neutropenia – Drug Profile 63
Product Description 63
Mechanism of Action 63
R&D Progress 63
F-627 – Drug Profile 64
Product Description 64
Mechanism of Action 64
R&D Progress 64
filgrastim – Drug Profile 65
Product Description 65
Mechanism of Action 65
R&D Progress 65
filgrastim – Drug Profile 66
Product Description 66
Mechanism of Action 66
R&D Progress 66
filgrastim – Drug Profile 67
Product Description 67
Mechanism of Action 67
R&D Progress 67
filgrastim – Drug Profile 68
Product Description 68
Mechanism of Action 68
R&D Progress 68
filgrastim – Drug Profile 69
Product Description 69
Mechanism of Action 69
R&D Progress 69
filgrastim – Drug Profile 70
Product Description 70
Mechanism of Action 70
R&D Progress 70
filgrastim – Drug Profile 72
Product Description 72
Mechanism of Action 72
R&D Progress 72
filgrastim (recombinant) – Drug Profile 73
Product Description 73
Mechanism of Action 73
R&D Progress 73
GW-003 – Drug Profile 74
Product Description 74
Mechanism of Action 74
R&D Progress 74
HM-10460A – Drug Profile 75
Product Description 75
Mechanism of Action 75
R&D Progress 75
IRX-4310 – Drug Profile 76
Product Description 76
Mechanism of Action 76
R&D Progress 76
lipegfilgrastim – Drug Profile 77
Product Description 77
Mechanism of Action 77
R&D Progress 77
Myelo-001 – Drug Profile 78
Product Description 78
Mechanism of Action 78
R&D Progress 78
pegfilgrastim – Drug Profile 79
Product Description 79
Mechanism of Action 79
R&D Progress 79
pegfilgrastim – Drug Profile 80
Product Description 80
Mechanism of Action 80
R&D Progress 80
pegfilgrastim – Drug Profile 81
Product Description 81
Mechanism of Action 81
R&D Progress 81
pegfilgrastim – Drug Profile 82
Product Description 82
Mechanism of Action 82
R&D Progress 82
pegfilgrastim – Drug Profile 83
Product Description 83
Mechanism of Action 83
R&D Progress 83
pegfilgrastim – Drug Profile 84
Product Description 84
Mechanism of Action 84
R&D Progress 84
pegfilgrastim – Drug Profile 85
Product Description 85
Mechanism of Action 85
R&D Progress 85
pegfilgrastim – Drug Profile 86
Product Description 86
Mechanism of Action 86
R&D Progress 86
Recombinant Protein for Chemotherapy Induced Neutropenia – Drug Profile 87
Product Description 87
Mechanism of Action 87
R&D Progress 87
romyelocel-L – Drug Profile 88
Product Description 88
Mechanism of Action 88
R&D Progress 88
TXA-302 – Drug Profile 89
Product Description 89
Mechanism of Action 89
R&D Progress 89
WBI-2100 – Drug Profile 91
Product Description 91
Mechanism of Action 91
R&D Progress 91
Chemotherapy Induced Neutropenia – Recent Pipeline Updates 92
Chemotherapy Induced Neutropenia – Dormant Projects 98
Chemotherapy Induced Neutropenia – Discontinued Products 100
Chemotherapy Induced Neutropenia – Product Development Milestones 101
Featured News & Press Releases 101
Dec 08, 2014: Generon Presents the Global Phase II Study Results for F-627 (benegrastim) at the American Society of Hematology 56th Annual Meeting at San Francisco 101
Sep 09, 2014: Spectrum Pharmaceuticals Makes Decision to Advance SPI-2012, a Novel Long-Acting GCSF, to Phase 3 Due to Positive Phase 2 Results in its Collaboration Program with Hanmi Pharm 102
May 28, 2014: Spectrum Pharmaceuticals Completes Enrollment in Phase 2 Trial of SPI-2012 – A Novel Long-Acting Granulocyte Colony Stimulating Factor to Treat Chemotherapy-induced Neutropenia 103
Mar 25, 2014: Sandoz receives approval for biosimilar filgrastim in Japan 103
Nov 18, 2013: Teva announces Launch of LONQUEX Injection 104
Jul 22, 2013: Zarzio overtakes Neupogen and Granocyte to become most prescribed daily G-CSF in Europe 105
Jun 03, 2013: Teva’s Lonquex Receives Positive Opinion From CHMP For Reduction Of Chemotherapy-induced Neutropenia 105
Apr 25, 2013: Sandoz Files For Marketing Authorization Of Biosimilar Filgrastim In Japan 106
Apr 08, 2013: Spectrum Pharma Initiates Phase II Study Of Long-acting GCSF Drug Candidate SPI-2012 For Treatment Of Chemotherapy-induced Neutropenia 106
Jan 07, 2013: Generon Initiates Phase I/II Clinical Trial Of F-627 For Treatment Of Breast Cancer In China 107
Appendix 108
Methodology 108
Coverage 108
Secondary Research 108
Primary Research 108
Expert Panel Validation 108
Contact Us 109
Disclaimer 109
【レポート販売概要】
■ タイトル：化学療法誘発性好中球減少(Chemotherapy Induced Neutropenia)の治療薬パイプライン動向（2015年上半期版）■ 英文：Chemotherapy Induced Neutropenia - Pipeline Review, H1 2015
■ 発行日：2015年1月22日
■ 調査会社：Global Markets Direct
■ 商品コード：GMDHC6036IDB
■ 調査対象地域：グローバル
- 世界の小型自動車用OEバッテリー市場【2015年1月更新版】This latest just-auto report edition offers a global review of the OE batteries sector, its suppliers, top markets, technologies and market forecasts. This global market study offers: Automotive OE batteries market size estimates Latest technologies and trends Market share data tables Exclusive interviews with major companies Profiles of the major players including their strategies and prospects M …
- バタフライバルブの世界市場2015-2019Technavio’s market research analysts expect the global butterfly valves market to grow significantly, posting a CAGR of over 6% in the forecast period, which is driven by the booming oil and gas industry in Latin America, Africa, and the Middle East. The increasing demand from the oil and gas industry will drive the demand for butterfly valve due to an increase in exploration and upgradation activ …
- 世界の小型自動車用OE基礎ブレーキ装置市場【2015年1月更新版】This latest just-auto report edition offers a global review of the OE foundation braking sector, its suppliers, top markets, technologies and market forecasts. This global market study offers: Automotive OE foundation braking market size estimates Latest technologies and trends Market share data tables Exclusive interviews with major companies Profiles of the major players including their strategi …
- 保護コーティングの世界市場2016-2020：溶剤型コーティング、水性コーティング、粉体コーティングAbout Protective Coatings Protective coatings are generally layered as protective systems, where layers are systematically applied. These systems may be a single coat or can be a combination of multiple layers of same or different generic types. This together forms a coating system consisting of one or more coats, applied in a predetermined order by prescribed methods, and generally involves surfa …
- 電気電子機器廃棄物（E-Waste）管理の世界市場The e-waste management report highlights that it consists of toxic materials which, if not properly disposed, can lead to high levels of pollution. Hence, the government bodies are creating the awareness among individuals about the conservation of the environment and health. The report provides an in-depth analysis of various developments going on in this market, along with the key market trends t …
- アンチモン酸化スズ・ナノ粒子の世界市場2010-2025Antimony tin oxide nanoparticles/nanopowders (ATO-NPs) possess excellent optical properties, chemical and mechanical stabilities, and high conductivity. They are mainly used in electronics and optics applications, where they are utilized for their high electrical conductivity and optical transparency. This 13 page report from Future Markets, Inc. provides an insight into the antimony tin oxide nan …
- 世界の特殊カーボンブラック市場2015The Global Specialty Carbon Black Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Specialty Carbon Black industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Specialty Carbon Black market analysis is provided for the international markets including d …
- 世界の固定衛星サービス（Fixed Satellite Service）市場動向（2012-2016）TechNavio's analysts forecast the Global Fixed Satellite Service market to grow at a CAGR of 5.44 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing demand for TV and video transponders. The Global Fixed Satellite Service market has also been witnessing the increasing number of value-enhanced services offered by FSS operators. However, th …
- 腎細胞がん：グローバル臨床試験レビュー（2014年上半期）Renal Cell Carcinoma Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Renal Cell Carcinoma Global Clinical Trials Review, H1, 2014" provides data on the Renal Cell Carcinoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Renal Cell Carcinoma. It includes an overview of the trial numbers and their r …
- 細胞ベースアッセイの世界市場2015-2019About cell-based assay Cell-based assays are used to measure biochemical or cellular functions such as cell motility, morphology, cell proliferation, toxicity, and stem cell differentiation. The components of cell-based assays include instruments and consumables. These components are used for screening and analysis of the cell functionality. The ease-of-use and accuracy of measurements make them i …
- Bayshore Petroleum Corp.：石油・ガスの開発・生産動向及びコスト分析- Q3, 2013Bayshore Petroleum Corp. Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary Bayshore Petroleum Corp. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential …
- 脳深部刺激の世界市場：用途別（疼痛管理、てんかん、特発性振戦、OCD（強迫性障害 ）、うつ病、ジストニア、パーキンソン病）、地域別予測Global Deep brain stimulation Market to reach USD 2119.3 million by 2025. Global Deep brain stimulation Market valued approximately USD 795.64 million in 2016 is anticipated to grow with a healthy growth rate of more than 11.5% over the forecast period 2017-2025. Key factors which give growth to the Deep brain stimulation market are Expanding predominance of neurological ailments, for example, Par …
- 世界のCMV検査市場The report presents a detailed analysis of the Cytomegalovirus diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the CMV definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals - Comm …
- 自動車用マイクロコントローラの世界市場2019-2023Global Automotive Microcontrollers Market: About this market An automotive microcontroller is a single integrated circuit designed to perform a specific operation in an automotive electronic system. Technavio’s automotive microcontrollers market analysis considers sales from segments, including 32-bit microcontroller, 16-bit microcontroller, and 8-bit microcontroller. Our analysis also considers t …
- IPTV向けCDN（コンテンツデリバリネットワーク）サービスの世界市場The market leader’s offer differentiated services in the IPTV CDN market. Companies such as Alcatel-Lucent, Ericsson, AT&T, and Akamai Technologies are the top leaders in this market. Nowadays, the companies are concentrating more on the services offerings to differentiate themselves in the competition. The small and medium enterprises cannot afford in-house services for content delivery via IPTV …
